Cargando…
Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover
Non-alcoholic fatty liver disease (NAFLD) has emerged as one of the main causes of chronic liver disease worldwide. NAFLD comprises a group of conditions characterized by the accumulation of hepatic lipids that can eventually lead to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hep...
Autores principales: | Simon, Jorge, Ouro, Alberto, Ala-Ibanibo, Lolia, Presa, Natalia, Delgado, Teresa Cardoso, Martínez-Chantar, María Luz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982102/ https://www.ncbi.nlm.nih.gov/pubmed/31861664 http://dx.doi.org/10.3390/ijms21010040 |
Ejemplares similares
-
Apoptotic Sphingolipid Ceramide in Cancer Therapy
por: Huang, Wei-Ching, et al.
Publicado: (2011) -
Sphingolipids and ceramides in human aqueous humor
por: Aljohani, Ayman J., et al.
Publicado: (2013) -
Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease
por: Martínez-Chantar, María Luz, et al.
Publicado: (2021) -
Ceramide and ceramide 1-phosphate in health and disease
por: Arana, Lide, et al.
Publicado: (2010) -
Sphingolipid and Ceramide Homeostasis: Potential Therapeutic Targets
por: Young, Simon A., et al.
Publicado: (2012)